Navigation Links
Molecular Diagnostics in Genetic Testing - 2013 Study Analyzes the Size and Growth of the Molecular Diagnostics in Genetic Testing Market

DUBLIN, October 1, 2013 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Molecular Diagnostics in Genetic Testing" report to their offering.


Molecular diagnostics in genetic testing brings advanced analytical techniques to the diagnosis and treatment of genetic disorders. The confluence of breakthroughs in genomics and proteomics and the development of microarray devices to measure analytes in the blood and various body tissues are driving significant growth in the segment.

Major developments include the integration of specialty labs and gene expression profiling into clinical practice, the introduction and rapid growth of cell-free fetal DNA prenatal testing, the advancement of companion diagnostics for drug development, the widespread installed base of automated instruments for molecular testing and the development of personalized medicine. The genetic testing space is one of the most profitable sectors of molecular diagnostics and is expected to be an area of high growth and corporate change throughout the forecast period.

This report describes the emerging field of molecular diagnostics in genetic testing. This review analyzes the size and growth of the molecular diagnostics in genetic testing market, including the factors that influence the various market segments within it and the dollar volume of sales, both in the United States and worldwide. Moreover, this analysis profiles the leading companies focused on the molecular diagnostics for genetic testing sector.

Companies Mentioned

- Abbott Laboratories
- Beckman Coulter
- CombiMatrix
- EntroGen, Inc
- Genmark Diagnostics, Inc
- Genomic Health
- Hologic, Inc
- Illumina, Inc
- IntegenX
- Laboratory Corporation of America Holdings
- Life Technologies Corporation
- Luminex Corporation
- Myriad Genetics, Inc
- Natera
- NetBio
- PerkinElmer Genetics
- Progenika, Inc
- Roche Diagnostics
- Sequenom, Inc
- Signature Genomics
- Spartan Bioscience, Inc
- Transgenomic, Inc

For more information visit

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Biotech Industry Executives Summit (10/8) to Advance the Supply Chain with Focus on Serialization, Strategic Sourcing, Clinical Supply and Molecular Diagnostics
2. Rising Interest in Molecular Biology Research Drives Demand for qPCR and dPCR Instrumentation, According to a Soon to be Released Report by Global Industry Analysts, Inc.
3. MRIGlobal Engages Industry Expert in Expansion of Molecular Diagnostic Division
4. Reproducing natures chemistry: Researchers alter molecular properties in a new way
5. Curemark Enters into Research Collaboration with The Molecular Sciences Institute (VTT/MSI)
6. Molecular Cytogenetics Market is Expected to Reach USD 1.97 Billion Globally in 2019: Transparency Market Research
7. Molecular Diagnostics: Technologies, Markets and Companies - 2013 Report
8. Molecular Biomarkers for Cancer Detection and Management
9. Managing Antibiotic-Resistant Bloodstream Infections with Rapid Molecular Diagnostics educational webinar hosted by Nanosphere and Xtalks
10. The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools
11. NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
Breaking Biology Technology:
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... LA JOLLA, Calif. , Oct. 29, 2015 /PRNewswire-USNewswire/ ... released a new report titled, "DNA Synthesis and Biosecurity: ... how well the Department of Health and Human Services ... was issued in 2010. --> ... advances, but it also has the potential to pose ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
Breaking Biology News(10 mins):